Stay updated on Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.

Latest updates to the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page
- Check2 days agoChange DetectedThe page shows a new revision tag (v3.6.5) replacing the previous v3.6.4, indicating a minor platform update to the page that does not change study content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe site revision was updated from v3.6.3 to v3.6.4, signalling a maintenance/version update to the ClinicalTrials.gov page infrastructure. The update does not modify the study details, eligibility criteria, or other content presented on the page.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a minor update to the page version. This change does not modify study data, eligibility criteria, or results.SummaryDifference0.0%

- Check45 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a small internal update to the page's version history. This change does not modify the public study content or visible information.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page now displays 'No longer looking for participants' under recruitment status, indicating enrollment is closed. Additionally, new help/navigation sections—'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study'—were added, while the 'Intervention/Treatment' heading was updated in formatting and site revision metadata updated to Revision: v3.6.0.SummaryDifference0.3%

- Check67 days agoChange DetectedRevision label on the page changed from v3.5.4 to v3.5.5. This represents a minor update to the page with no substantive changes to study content.SummaryDifference0.0%

Stay in the know with updates to Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.